IIT Jodhpur’s Study On Centrosome Can Help Pave Way For Developing New Treatments For Cancer And Rare Diseases
Jodhpur: The Indian Institute of Technology (IIT) Jodhpur is making significant strides in the field of cancer research through its innovative study on the centrosome. This research is led by Dr. Priyanka Singh, an Associate Professor in the Department of Bioscience and Bioengineering, and her dedicated team. Their work focuses on understanding the structure and function of the centrosome, a vital component in cell division that maintains cellular balance.
Understanding the Centrosome
The centrosome can be likened to a traffic control center within a bustling city, where proteins, molecules, and other biological components operate much like vehicles on busy roads. Just as traffic signals regulate the flow of traffic, the centrosome plays a crucial role in managing cell division and ensuring that cellular processes run smoothly.
Dr. Singh’s research emphasizes the importance of the centrosome in maintaining cellular equilibrium. Imbalances in centrosome function can lead to severe diseases, including cancer and rare developmental disorders such as microcephaly. “We aim to uncover the precise blueprint of cell function to halt cancer at its origin, while sparing healthy cells,” Dr. Singh stated.
The Role of Centrosomes in Cell Division
During cell division, centrosomes duplicate and migrate to opposite ends of the cell, forming microtubules that facilitate the division of chromosomes into two equal sets. However, an abnormal number of centrosomes can result in uncontrolled cell division, a hallmark of cancer. Dr. Singh’s research has identified a critical protein known as PLK4, which acts as a regulatory switch, toggling between two states to maintain balance during cell division.
Link Between Proteins and Cancer
One of the groundbreaking findings of Dr. Singh’s team is the unexpected link between the STIL protein and the BRCA1 tumor suppressor protein. This discovery sheds light on how the cellular system itself can play an anti-cancer role. “We are also investigating how mutations in centrosome-associated proteins contribute to rare diseases like microcephaly,” Dr. Singh explained.
Mutations and Their Impact
The research has revealed that two distinct types of mutations in the CPAP protein can lead to abnormal centrosome sizes and multiplication. Such imbalances can cause serious developmental disorders. Interestingly, some cancer cells exhibit an increased number of centrosomes but manage to fuse them, creating a deceptive appearance of normal division. Dr. Singh’s team has identified specific mutations that facilitate this process and is developing chemicals that can disrupt these centrosome clusters.
Implications for Cancer Therapy
This innovative approach could pave the way for new cancer therapies. By targeting the mechanisms that allow cancer cells to evade normal division processes, researchers hope to create treatments that are more effective and less harmful to healthy cells. “Our findings could provide a new direction for future cancer therapy,” Dr. Singh remarked.
Future Directions
As the research progresses, Dr. Singh and her team aim to delve deeper into the complexities of centrosome function and its implications for both cancer and rare diseases. The potential for developing targeted therapies based on these findings could revolutionize the treatment landscape for patients suffering from these conditions.
Conclusion
The ongoing research at IIT Jodhpur represents a significant advancement in our understanding of cell biology and disease mechanisms. By focusing on the centrosome, Dr. Singh and her team are not only uncovering the intricacies of cell division but also laying the groundwork for innovative treatments that could change the lives of many.
Note: This article is based on the latest research findings from IIT Jodhpur and aims to highlight the importance of centrosome studies in developing new therapies for cancer and rare diseases.
